U.S. Should Develop Strategy To Guide Biological Technology Research Efforts

Foreign Policy: Zika Is Just the First Front in the 21st-Century Biowar
James Stavridis, dean of the Fletcher School of Law and Diplomacy at Tufts University

“…The United States needs to continue its research efforts [in biological technology], but, equally important, it needs to develop a coherent and cohesive biological strategy to guide those efforts. … There are three key components to preparing for the biological revolution. First, we need an international approach that seeks to limit the proliferation of highly dangerous technologies … and fosters cooperation in the case of contagion or a transnational biological threat. … Second, the American government’s interagency process must become more adept at addressing both the scientific advances and the security challenges emanating from the world of biological research. … Finally, all this will require a powerful level of private-public cooperation. … As citizens, both in the United States and globally, we spend far too much time focused on information and cyber-technologies. The weaponization of biology is coming, and coming quickly. And our ability to control that process — or not — will determine our destiny” (8/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.